期刊文献+

重视变态反应性结膜炎治疗中非甾体抗炎药物的应用 被引量:14

Consideration of application of non-steroidal anti-inflammatory drugs in the treatment of allergic conjunctivitis
下载PDF
导出
摘要 近年来随着工业化进程的加快,变态反应性结膜炎的发生率逐渐升高.目前,变态反应性结膜炎的治疗以眼局部治疗为主,主要目的在于针对病因,减轻症状和预防并发症.变态反应性结膜炎的治疗药物包括抗组胺药、肥大细胞稳定剂、双效作用药物(稳定肥大细胞/抗组胺)、非甾体抗炎药(NSAIDs)、糖皮质激素及免疫抑制剂六大类.抗组胺药、肥大细胞稳定剂、双效作用药物的主要作用是减轻眼部瘙痒、结膜充血等症状和体征,也可用于急性变态反应性结膜炎患者,而NSAIDs、糖皮质激素及免疫抑制剂则用于症状严重患者或慢性病例.糖皮质激素类药物治疗变态反应性结膜炎效果显著,可作用于过敏反应的多个环节,但是长期应用可能会导致眼压升高、视力障碍、视野缺损和后囊下白内障,有角膜溃疡的患者更应谨慎使用.免疫抑制剂具有抑制免疫的作用,可抑制局部或机体异常的免疫反应,但由于价格较高及局部刺激性强等不良反应,故也不宜长期应用.NSAIDs具有良好的抗炎效果,作用温和,刺激性小,目前在眼表变态反应性结膜炎中广泛应用. Allergic conjunctivitis is a very common pathology and its incidence has increased in developing countries with the development of industrialization.At present,the therapy of allergic conjunctivitis is mainly the use of topical eyedrops to eliminate causative factors,relieve symptoms and prevent complications.The drugs used in allergic conjunctivitis have 6 groups,including antihistamine,mastocyte stabilizer,drugs with dual effects (antihistamine and mastocyte stabilizer),non-steroidal anti-inflammatory drugs (NSAIDs),glucocorticoids and immunosuppressors.The goals of topical use of antihistamine,mastocyte stabilizer and drugs of dual effects are to remove the itching and hyperaemia of eye or to treat the patients with acute allergic conjunctivitis; while NSAIDs,glucocorticoids and immunosuppressors are used for the patients with severe or chronic allergic conjunctivitis.The glucocorticoid drugs are more effective because of their arresting effects in several links of the allergic response.Nevertheless,the long-term use of glucocorticoids probably results in ocular hypertension or posterior subcapsular cataract,furthermore,glucocorticoid drugs should be more cautionary in the application of the patients with corneal ulcer.Immunosuppressors inhibit abnormal immune responses,but these drugs should not be used for a long term because of higher cost and adverse effects.NSAIDs have a good anti-inflammatory effect and less irritant,so the topical use of NSAIDs for allergic conjunctivitis appears to be a better choice nowadays.
作者 李莹
出处 《中华实验眼科杂志》 CAS CSCD 北大核心 2014年第3期196-199,共4页 Chinese Journal Of Experimental Ophthalmology
关键词 结膜炎 变态反应性 药物疗法 眼滴剂 治疗 抗变态反应制剂 治疗 抗炎药物 治疗 非甾体抗炎药 治疗 Conjunctivitis, allergic/drug therapy Ophthalmic solution/therapeutic use Anti-allergic agent/therapeutic use Anti-inflammatory agent/therapeutic use Non-steroidal/therapeutic use
  • 相关文献

参考文献25

  • 1李莹,张潇,吕岚,袁进,孙国强.过敏性结膜炎的流行病学及奥洛他定滴眼液开放性多中心治疗的初步效果[J].眼科,2008,17(3):166-170. 被引量:49
  • 2Mishra GP,Tamboli V,Jwala J,et al.Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis[J].Recent Pat Inflamm Allergy Drug Discov,2011,5:26-36.
  • 3Bielory L.Allergic conjunctivitis:the evolution of therapeutic options[J].Allergy Asthma Proc,2012,33:129-139.
  • 4Schalnus R.Topical nonsteroidal anti-inflammatory therapy in ophthalmology[J].Ophthalmologica,2003,217:89-98.
  • 5Schechter BA.Ketorolac tromethamine 0.4% as a treatment for allergic conjuctivitis[J].Expert Opin Drug Metab Toxico1,2008,4:507-511.
  • 6Leonardi A,Busato F,Fregona I,et al.Anti-inflammatory and antiallergic effects of ketorolac tromethamine in the conjunctival provocation model[J].Br J Ophthalmo1,2000,84:1228-1232.
  • 7Tinkelman DG,Rupp G,Kaufman H,et al.Double-masked,pairedcomparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis[J].Surv Ophthalmol,1993,38 Suppl:133-140.
  • 8Li Z,Mu G,Chen W,et al.Comparative evaluation of topical pranoprofen and fluorometholone in cases with chronic allergic conjunctivitis[J].Cornea,2013,32:579-582.
  • 9Fujishima H,Fukagawa K,Takano Y,et al.Comparison of efficacy of bromfenac sodium 0.1% ophthalmic solution and fluorometholone 0.02% ophthalmic suspension for the treatment of allergic conjunctivitis[J].J Ocul Pharmacol Ther,2009,25:265-270.
  • 10Notivol R,Marttnez M,Bergamini MV.Treatment of chronic nonbacterial conjunctivitis with a cyclo-oxygenase inhibitor or a corticosteroid.Pranoprofen Study Group[J].Am J Ophthalmol,1994,117:651-656.

二级参考文献18

  • 1刘祖国,肖启国.过敏性结膜炎的诊治[J].中华眼科杂志,2004,40(7):500-502. 被引量:63
  • 2刘祖国,姚勇,孙秉基,孙兴怀,谢汉平,王红,万修华,崔敏,陈龙山,张梅.过敏性结膜炎的临床特点[J].中国实用眼科杂志,2004,22(9):694-697. 被引量:94
  • 3邹留河,吴珺.充分认识儿童过敏性结膜炎的干眼症问题[J].眼科,2007,16(3):153-155. 被引量:17
  • 4Mehzer EO. Evaluating rhinitis: clinical rhinomanometric and cytological assessment. J Allergy Clin Immunol. 1988. 82: 900-908.
  • 5Abelson MB, George MA , Garofalo C. Differential diagnosis of ocular disorder. Ann Allergy, 1993, 70: 95-105.
  • 6Zierhut M, Schlote T. Differential diagnosis of allergic ocular disorders. Acta Ophthalmol Stand, 1999, 228 (Suppl) : 26-30.
  • 7Belfort R, Marbeck P, Hsu CC, et al. Epidemiological study of 134 subjects with allergic conjunctivitis A eta Op hthalm ol S cand 2000, 230 ( Suppl): 38-40.
  • 8Keane-Myers A. The pathogenesis of allergic conjunctivitis. Curr Allergy Asthma Rep, 2001, 1: 550-557.
  • 9McGill JI, Holgate ST, Church MK, et al. Allergic eye disease mechanisms. Br J Ophthalmol, 1998, 82: 1203-1214.
  • 10[1]Ogawa T, Ogasawara A. Effects of Proanoprofen on rabbit uveitis. Journal of the Eye,1988,5: 1335

共引文献216

同被引文献82

引证文献14

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部